Infectious Disease and Microbiology – Cunninghamella bertholletiae

Overview

Cunninghamella bertholletiae is a rare filamentous fungal pathogen that can cause mucormycosis, particularly in severely immunocompromised patients. Infection can be rapidly progressive and invasive, with the potential for extensive tissue destruction and dissemination.

⸻

Microbiologic Characteristics

C. bertholletiae is a filamentous fungus (mold) traditionally classified among the organisms causing mucormycosis.

The organism characteristically produces:

• Broad, hyaline hyphae

• Nonseptate or sparsely septate hyphae

• Filamentous growth

Like other causes of mucormycosis, the fungus can invade blood vessels, resulting in vascular thrombosis, tissue ischemia, and necrosis.

⸻

Epidemiology

Cunninghamella bertholletiae is distributed worldwide, but human infection is rare.

Disease occurs predominantly in patients with impaired host defenses.

⸻

Major Risk Groups

Infection occurs more frequently in:

• Immunosuppressed patients

• Patients receiving intensive immunosuppressive therapy

• Patients with severe underlying disease

• Patients undergoing hemodialysis

Profound immunosuppression substantially increases the risk of invasive fungal disease.

⸻

Mucormycosis

The principal infection caused by C. bertholletiae is mucormycosis, historically referred to as zygomycosis.

Mucormycosis is an aggressive invasive fungal infection characterized by fungal invasion of tissues and blood vessels.

⸻

Angioinvasion and Tissue Necrosis

A major pathogenic feature is angioinvasion.

Fungal hyphae invade blood vessels, which can lead to:

Vascular invasion → thrombosis → impaired blood supply → tissue infarction and necrosis

This process helps explain the rapid progression and potentially high severity of invasive mucormycosis.

⸻

Clinical Manifestations

Depending on the site of infection and degree of immunosuppression, mucormycosis may involve:

• Lungs

• Sinuses and rhinocerebral structures

• Skin and soft tissues

• Gastrointestinal tract

• Multiple organs in disseminated infection

Pulmonary or disseminated disease is particularly concerning in severely immunocompromised patients.

⸻

Diagnosis

Diagnosis requires rapid recognition because invasive mucormycosis can progress quickly.

The principal diagnostic methods are:

• Identification of fungal hyphae in tissue biopsy

• Fungal culture

⸻

Tissue Biopsy

Histopathologic examination may demonstrate characteristic broad, hyaline, sparsely septate or nonseptate hyphae invading tissue.

Evidence of vascular invasion, thrombosis, infarction, and necrosis supports the diagnosis of invasive mucormycosis.

⸻

Culture

Fungal culture can help identify Cunninghamella and distinguish it from other molds responsible for invasive fungal disease.

Whenever possible, both histopathology and culture should be obtained.

⸻

Treatment

The traditional treatment for severe C. bertholletiae infection is:

Intravenous amphotericin B

Because mucormycosis is potentially life-threatening, antifungal treatment should be initiated promptly when invasive disease is strongly suspected.

⸻

Additional Antifungal Therapy

Older literature contains limited information regarding the effectiveness of azole antifungals against Cunninghamella.

Itraconazole has historically been evaluated, but evidence for its effectiveness is limited.

Selection of antifungal therapy should take into account the organism, disease severity, infection site, susceptibility information, and patient characteristics.

⸻

Surgical Management

When anatomically feasible, surgical removal of infected or necrotic tissue can be an important component of mucormycosis treatment.

Management may therefore require:

Systemic antifungal therapy + aggressive surgical debridement + correction of underlying risk factors

⸻

High-Yield Clinical Pattern

Severely immunocompromised or hemodialysis patient

Rapidly progressive invasive fungal infection

Broad, nonseptate/sparsely septate hyaline hyphae in tissue

→ Consider mucormycosis, including Cunninghamella bertholletiae

⸻

Exam Essentials

Organism: Cunninghamella bertholletiae

Type: Filamentous fungus (mold)

Hyphae: Broad, hyaline, nonseptate or sparsely septate

Distribution: Worldwide

Frequency: Rare

Major risk factor: Immunosuppression

Additional association: Hemodialysis

Major disease: Mucormycosis

Important pathogenic feature: Angioinvasion with thrombosis and tissue necrosis

Diagnosis: Tissue biopsy + fungal culture

Traditional treatment: IV amphotericin B

Older alternative studied: Itraconazole, with limited supporting data

⸻

Key clinical pearl: Cunninghamella bertholletiae should be considered in a severely immunocompromised patient with rapidly invasive mucormycosis and broad, sparsely septate or nonseptate hyphae on tissue biopsy.